Wed, February 24, 2016
Tue, February 23, 2016
Mon, February 22, 2016
Fri, February 19, 2016
Thu, February 18, 2016
Wed, February 17, 2016
Tue, February 16, 2016
Fri, February 12, 2016
Thu, February 11, 2016
Wed, February 10, 2016
Tue, February 9, 2016
Mon, February 8, 2016
Fri, February 5, 2016
Thu, February 4, 2016
Wed, February 3, 2016
Tue, February 2, 2016
Mon, February 1, 2016
Fri, January 29, 2016
Thu, January 28, 2016
Wed, January 27, 2016
Tue, January 26, 2016

Maury Raycroft Downgraded (BCRX) to Strong Buy and Decreased Target to $2 on, Feb 9th, 2016

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. y-and-decreased-target-to-2-on-feb-9th-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Maury Raycroft of Jefferies, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Strong Buy and Decreased Target from $14 to $2 on, Feb 9th, 2016.

Maury has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Maury's Rating of Hold.



This is the rating of the analyst that currently disagrees with Maury


  • Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Wednesday, November 11th, 2015